Select Bibliography

Filter by any of these (after searching):

Wender, Donald B

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 9 items

Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.

Barton, Debra L , Wender, Donald B , Sloan, Jeff A , Dalton, Robert J ... - - J Natl Cancer Inst - 2007

Manuscript - Primary - Primary - Symptom Inter - NCCTG-N02C3

Phase II Trial of Oral Topotecan and Intravenous Carboplatin With G-CSF Support in Previously Untreated Patients With Extensive Stage Small Cell Lung Cancer

Bryce, Alan H. , Mattar, Bassam , Hillman, Shauna L. , Adjei, Alex A. ... - - Am J Clin Oncol - 2010

Manuscript - Primary - Primary - Respiratory - NCCTG-0027

Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.

Croghan, Ivana T , Hurt, Richard D , Dakhil, Shaker R ... - - Mayo Clin Proc - 2007

Manuscript - Primary - Primary - Prevention - NCCTG-N99C4

A Front-Line “Window of Opportunity” Phase II Study of Sorafenib in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)– A North Central Cancer Treatment Group Study N03261

Dy, Grace K. , Hillman, Shauna L. , Rowland, Kendrith M. ... - - Cancer - 2010

Manuscript - Primary - Primary - Respiratory - N0326

Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer.

Garces, Yolanda I , Okuno, Scott H , Schild, Steven E ... - - Int J Radiat Oncol Biol Phys - 2007

Manuscript - Primary - Primary - Respiratory - N9923

Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7

Grothey, Axel , Nikcevich, Daniel A. , Sloan, Jeff A. ... - - J Clin Oncol - 2011

Manuscript - Primary - Primary - Symptom Inter - N04C7

Prophylactic Tetracycline Does Not Diminish the Severity of Epidermal Growth Factor Receptor (EGFR) Inhibitor Induced Rash: Results from the North Central Cancer Treatment Group (Supplementary N03CB)1

Jatoi, Aminah , Dakhil, Shaker R. , Sloan, Jeff A. , Kugler, John W. ... - - Support Care Cancer - 2011

Manuscript - Secondary - Primary - Symptom Inter - N03CB

Bendamustine and rituximab and lenalidomide (BRR) in the treatment of relapsed and refractory low grade non-Hodgkin lymphoma (NHL): Final results of phase 1 study NCCTG N1088/Alliance

Nowakowski, Grzegorz S. , LaPlant, Betsy , Macon, William R. ... - ASCO - J Clin Oncol - 2015

Abstract - Primary - Primary - Lymphoma - N1088

Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).

Schild, Steven E , Bonner, James A , Hillman, Shauna ... - - J Clin Oncol - 2007

Manuscript - Primary - Primary - Respiratory - NCCTG-95-20-53